Hideki Asakawa
Overview
Explore the profile of Hideki Asakawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
338
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakamura A, Shigekawa T, Asakawa H, Park K, Baba N
Gan To Kagaku Ryoho
. 2021 Oct;
48(10):1251-1254.
PMID: 34657057
Palbociclib, a CDK4/6 inhibitor, is found to be an effective therapeutic drug in the treatment of estrogen receptor positive (ER+)metastatic breast cancer. In this report, we describe a case of...
2.
Park K, Nakamura A, Asakawa H, Shigekawa T, Soejima K, Kawahara Y, et al.
Gan To Kagaku Ryoho
. 2021 Aug;
48(8):1065-1068.
PMID: 34404078
A 57-year-old Japanese woman underwent partial mastectomy of the right breast and sentinel lymph node biopsy in July 2005. The diagnosis was mucinous carcinoma with negative margins and no lymph...
3.
Neoadjuvant Endocrine Therapy for Operable Breast Cancer: A Retrospective Analysis of Real-World Use
Iwamoto M, Takei H, Ninomiya J, Asakawa H, Kurita T, Yanagihara K, et al.
J Nippon Med Sch
. 2021 Mar;
88(5):448-460.
PMID: 33692294
Background: A retrospective study of the real-world use of neoadjuvant endocrine therapy (NET) is important for standardizing the role of NET in breast cancer care. Methods: In a consecutive series...
4.
Mita K, Fujino K, Asakawa H, Matsuyama T, Hayashi T, Ito H
Asian J Endosc Surg
. 2019 Apr;
13(1):71-76.
PMID: 30931549
Introduction: In patients receiving chronic anticoagulation agents, antiplatelet agents, or both, perioperative antithrombotic therapy for inguinal hernia repair requires an understanding of potential side-effects-specifically, the postoperative bleeding risks. In the...
5.
Mita K, Ito H, Katsube T, Tsuboi A, Yamazaki N, Asakawa H, et al.
J Gastrointest Surg
. 2017 Sep;
21(12):1993-1999.
PMID: 28940122
Background: The prognosis and survival of patients with advanced gastric cancer is poor. Although completeness of resection (R0) is one of the most important factors affecting survival, multivisceral resection (MVR)...
6.
Takahashi K, Ito H, Hashimoto M, Mita K, Asakawa H, Hayashi T, et al.
World J Surg Oncol
. 2017 Aug;
15(1):161.
PMID: 28836988
Background: The study aimed to evaluate the prognosis for patients with colorectal cancer who underwent surgery while receiving antithrombotic therapy (ATT) across all disease stages and for patients at disease...
7.
Takahashi K, Ito H, Katsube T, Hashimoto M, Mita K, Asakawa H, et al.
J Vasc Surg Venous Lymphat Disord
. 2017 Apr;
5(3):339-345.
PMID: 28411700
Background: The aim of the study was to evaluate the clinical results and postoperative complications, especially recanalization or bleeding complications, in patients with saphenous varicose veins undergoing endovenous laser ablation...
8.
Mita K, Ito H, Ota E, Takahashi K, Hashimoto M, Asakawa H, et al.
Anticancer Res
. 2017 Mar;
37(3):1329-1333.
PMID: 28314299
Background/aim: The aim of this study was to investigate the efficacy and safety of S-1 plus low-dose cisplatin for stage IIIB and stage IIIC gastric cancer patients after D2 gastrectomy....
9.
Takahashi K, Ito H, Katsube T, Tsuboi A, Hashimoto M, Ota E, et al.
Asian J Endosc Surg
. 2016 Sep;
10(1):63-65.
PMID: 27651120
Chilaiditi syndrome is defined as the interposition of the bowel between the liver and right diaphragm. It is a rare disease and may be difficult to diagnose and manage. Treatment...
10.
Takahashi K, Ito H, Katsube T, Tsuboi A, Hashimoto M, Ota E, et al.
Surg Endosc
. 2016 Jun;
31(2):567-572.
PMID: 27287908
Background: The aim of this study was to identify factors associated with perioperative morbidity among patients who underwent laparoscopic gastrectomy while receiving antithrombotic therapy (ATT). Patients And Method: This retrospective...